Cherry L. Estilo

Cherry L. Estilo

Auto-generated profile, based on publicly available information

Cherry L. Estilo

Dental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2012 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
SPSmruti Pushalkar
Smruti Pushalkar
XJXiaojie Ji
Xiaojie Ji
YLYihong Li
Yihong Li
CECherry Estilo
Cherry Estilo
RYRamanathan Yegnanarayana
Ramanathan Yegnanarayana
DSDeepak Saxena
Deepak Saxena
Background: Bacterial infections have been linked to malignancies due to their ability to induce chronic inflammation. We investigated the association of oral bacteria in oral squamous cell carcinoma (OSCC/tumor) tissues and compared with adjacent non-tumor mucosa sampled 5 cm distant from the same patient (n = 10). By using culture-independent 16S rRNA approaches, denaturing gradient gel electrophoresis (DGGE) and cloning and sequencing, we assessed the total bacterial diversity in these clinical samples. Results: DGGE fingerprints showed variations in the band intensity profiles within non-tumor and tumor tissues of the same patient and among the two groups. The clonal analysis indicated that from a total of 1200 sequences characterized, 80 bacterial species/phylotypes were detected representing six phyla, Firmicutes, Bacteroidetes, Proteobacteria, Fusobacteria, Actinobacteria and uncultivated TM7 in non-tumor and tumor libraries. In combined library, 12 classes, 16 order, 26 families and 40 genera were observed. Bacterial species, Streptococcus sp. oral taxon 058, Peptostreptococcus stomatis, Streptococcus salivarius, Streptococcus gordonii, Gemella haemolysans, Gemella morbillorum, Johnsonella ignava and Streptococcus parasanguinis I were highly associated with tumor site where as Granulicatella adiacens was prevalent at non-tumor site. Streptococcus intermedius was present in 70% of both non-tumor and tumor sites. Conclusions: The underlying changes in the bacterial diversity in the oral mucosal tissues from non-tumor and tumor sites of OSCC subjects indicated a shift in bacterial colonization. These most prevalent or unique bacterial species/phylotypes present in tumor tissues may be associated with OSCC and needs to be further investigated with a larger sample size.

1 January 2017 in Oral Oncology
Verified
Journal Article
Closed access
AOAdepitan A. Owosho
Adepitan A. Owosho
CTC. Jillian Tsai
C. Jillian Tsai
RLRyan S. Lee
Ryan S. Lee
HFHaley Freymiller
Haley Freymiller
AKArvin Kadempour
Arvin Kadempour
CECherry L. Estilo
Cherry L. Estilo

12 January 2009 in BMC Cancer
Verified
Journal Article
Open access
PDF file
CECherry L Estilo
Cherry L Estilo
POPornchai O-Charoenrat
Pornchai O-Charoenrat
STSimon Talbot
Simon Talbot
NSNicholas D Socci
Nicholas D Socci
DCDiane L Carlson
Diane L Carlson
BSBuvanesh Singh
Buvanesh Singh
The present study is aimed at identifying potential candidate genes as prognostic markers in human oral tongue squamous cell carcinoma (SCC) by large scale gene expression profiling. The gene expression profile of patients (n=37) with oral tongue SCC were analyzed using Affymetrix HG_U95Av2 high-density oligonucleotide arrays. Patients (n=20) from which there were available tumor and matched normal mucosa were grouped into stage (early vs. late) and nodal disease (node positive vs. node negative) subgroups and genes differentially expressed in tumor vs. normal and between the subgroups were identified. Three genes, GLUT3, HSAL2, and PACE4, were selected for their potential biological significance in a larger cohort of 49 patients via quantitative real-time RT-PCR. Hierarchical clustering analyses failed to show significant segregation of patients. In patients (n=20) with available tumor and matched normal mucosa, 77 genes were found to be differentially expressed (P< 0.05) in the tongue tumor samples compared to their matched normal controls. Among the 45 over-expressed genes, MMP-1 encoding interstitial collagenase showed the highest level of increase (average: 34.18 folds). Using the criterion of two-fold or greater as overexpression, 30.6%, 24.5% and 26.5% of patients showed high levels of GLUT3, HSAL2 and PACE4, respectively. Univariate analyses demonstrated that GLUT3 over-expression correlated with depth of invasion (P<0.0001), tumor size (P=0.024), pathological stage (P=0.009) and recurrence (P=0.038). HSAL2 was positively associated with depth of invasion (P=0.015) and advanced T stage (P=0.047). In survival studies, only GLUT3 showed a prognostic value with disease-free (P=0.049), relapse-free (P=0.002) and overall survival (P=0.003). PACE4mRNA expression failed to show correlation with any of the relevant parameters. The characterization of genes identified to be significant predictors of prognosis by oligonucleotide microarray and further validation by real-time RT-PCR offers a powerful strategy for identification of novel targets for prognostication and treatment of oral tongue carcinoma.

20 August 2008 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
CECherry L. Estilo
Cherry L. Estilo
MFMonica Fornier
Monica Fornier
AFAzeez Farooki
Azeez Farooki
DCDiane Carlson
Diane Carlson
GBGeorge Bohle
George Bohle
JHJoseph M. Huryn
Joseph M. Huryn

22 September 2012 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
F(For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)
For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)
CMCesar Migliorati
Cesar Migliorati
IHIan Hewson
Ian Hewson
RLRajesh V. Lalla
Rajesh V. Lalla
HAHeliton Spindola Antunes
Heliton Spindola Antunes
SESharon Elad
Sharon Elad
The aim of this study was to review the available literature and define clinical practice guidelines for the use of laser and other light therapies for the prevention and treatment of oral mucositis.

1 August 2008 in The Oncologist
Verified
Journal Article
Closed access
PDF file
CECherry L. Estilo
Cherry L. Estilo
CPCatherine H. Van Poznak
Catherine H. Van Poznak
TWTijaana Wiliams
Tijaana Wiliams
GBGeorge C. Bohle
George C. Bohle
PLPhyu T. Lwin
Phyu T. Lwin
JHJoseph M. Huryn
Joseph M. Huryn
Cases of osteonecrosis of the jaw (ONJ) have been reported with an increasing frequency over the past 5 years. ONJ is most often identified in patients with cancer who are receiving intravenous bisphosphonate (IVBP) therapy, but it has also been diagnosed in patients receiving oral bisphosphonates for nonmalignant conditions. To further categorize risk factors associated with ONJ and potential clinical outcomes of this condition, we performed a retrospective study of patients with metastatic bone disease treated with intravenous bisphosphonates who have been evaluated by the Memorial Sloan-Kettering Cancer Center Dental Service between January 1, 1996 and January 31, 2006. We identified 310 patients who met these criteria. Twenty-eight patients were identified as having ONJ at presentation to the Dental Service and an additional 7 patients were subsequently diagnosed with ONJ. Statistically significant factors associated with increased likelihood of ONJ included type of cancer, duration of bisphosphonate therapy, sequential IVBP treatment with pamidronate followed by zoledronic acid, comorbid osteoarthritis or rheumatoid arthritis, and benign hematologic conditions. Our data do not support corticosteroid use or oral health as a predictor of risk for ONJ. Clinical outcomes of patients with ONJ were variable with 11 patients demonstrating improvement or healing with conservative management. Our ONJ experience is presented here.